# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and maintains $1...
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target fro...
Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $85 to...
Asset acquisition expands Merit's endoscopy portfolio with a minimally invasive solution for patients suffering from chroni...
Baird analyst David Rescott initiates coverage on Merit Medical Systems (NASDAQ:MMSI) with a Outperform rating and announces...
Jim Cramer says Corning has "not been able to generate the kind of return that I've wanted"; calls Recursion a "...